Cambridge life sciences entrepreneur Dr Andy Richards received the BioIndustry Association Lifetime Achievement Award at the Association’s annual gala dinner.
It continues to be a challenging environment for the sector and One Nucleus remains mindful of the need to work very hard to ensure that all our activities provide a tangible benefit for members. With this in mind the company has two brand new initiatives, writes One Nucleus CEO, Harriet Fear.
Nasdaq-quoted Accelrys, Inc, which has a major presence in Cambridge, has paid around $5 million cash for a long-term Swiss partner. The deal could eventually stack up to $10m based on future performance increments.
In 2012 there was estimated to be 308,000 patients remotely monitored by their healthcare provider for congestive heart failure (CHF), chronic obstructive pulmonary disease (COPD), diabetes, hypertension and mental health conditions worldwide. The majority of these were post-acute patients who have been hospitalised and discharged.
Researchers at the EMBL-European Bioinformatics Institute (EMBL-EBI) in Cambridge UK have created a way to store data in the form of DNA – a material that lasts for tens of thousands of years.
Antibodies technology powerhouse Abcam expects to report revenue growth of around 28 per cent for the half-year to December 31 despite global uncertainty.
Two major US companies have signed partnership deals with One Nucleus, the organisation that drives the Cambridge UK biomedical technology cluster.
Ithaka Life Sciences has teamed up with De Montfort University in the UK to market new technology designed to accelerate and cut the cost of developing new drugs and medicines.
- Antibody firm unveils mouse that roars
- Cambridge Consultants carves out new surgical landscape
- Galapagos acquires Cangenix in £1.5m deal
- Horizon lands Boehringer humdinger
- The changing face of dementia care
- Lab21 sells US lab operations
- Medical device veteran is PneumaCare’s new CEO
- Cambridge accelerates disease diagnostic programmes
- Groundbreaking electronic health record hits the cloud
- University engages with building technology pioneers
- CEO quitting PneumaCare
- LGC buys Quotient’s bioanalytical science arm
Page 52 of 129